The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
HIV Inhibitors Targeted at the Reverse Transcriptase
Abstract
HIV inhibitors targeted at the virus-associated reverse transcriptase (RT) can be divided into two groups, depending on whether they are targeted at the substrate or nonsubstrate binding site. To the first group belong the 2',3'-dideoxynucleosides (i.e., DDC, DDI), 3'-azido-2',3'-dideoxynucleosides (i.e., AZT), 3'-fluoro-2',3'-dideoxynucleosides (i.e., FLT), 2',3'-didehydro-2',3'-dideoxynucleosides (i.e., D4C, D4T) and carbocyclic derivatives thereof (i.e., carbovir), 2'-fluoro-ara-2',3'-dideoxynucleosides, 1,3-dioxolane derivatives (i.e., 2',3'-dideoxyl-3'-thiacytidine), oxetanocin analogues and carbocyclic derivatives thereof (i.e., cyclobut-G) and the 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) derivatives. These compounds need to be phosphorylated intracellularly to their triphosphate forms before they act as competitive inhibitors or alternate substrates (chain terminators) of HIV RT. The second group includes the tetrahydro-imidazo[4,5,l-jk][1,4]-benzodiazepin-2(1H)one (TIBO), 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT), dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one (nevirapine) and pyridin-2(1H)one derivatives, which interact as such, noncompetitively, with a specific allosteric binding site of HIV-1 RT. Compounds belonging to the two different groups may give rise to synergism which combined, and, likewise, viral resistance to the compounds may arise through different mutations, depending on the nature of the compounds and the group to which they belong.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,642
Self-citationFurman, P. A., Fyfe, J. A., St Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., & Mitsuya, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8333 · Cited by 1,347
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,039
A novel selective broad-spectrum anti-DNA virus agent
Clercq, E. D., Holý, A., Rosenberg, I., Sakuma, T., Balzarini, J., & Maudgal, P. C. (1986) · Nature · doi:10.1038/323464a0 · Cited by 764
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
Merluzzi, V. J., Hargrave, K. D., Labadia, M., Grozinger, K., Skoog, M., Wu, J. C., Shih, C.-K., Eckner, K., Hattox, S., Adams, J., et al. (1990) · Science · doi:10.1126/science.1701568 · Cited by 743
Molecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
Baba, M., Pauwels, R., Herdewijn, P., De Clercq, E., Desmyter, J., & Vandeputte, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90460-8 · Cited by 342
Self-citationBaba, M., Tanaka, H., De Clercq, E., Pauwels, R., Balzarini, J., Schols, D., Nakashima, H., Perno, C.-F., Walker, R. T., & Miyasaka, T. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92756-3 · Cited by 288
Self-citationSt Clair, M. H., Richards, C. A., Spector, T., Weinhold, K. J., Miller, W. H., Langlois, A. J., & Furman, P. A. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1972 · Cited by 281
Goldman, M. E., Nunberg, J. H., O'Brien, J. A., Quintero, J. C., Schleif, W. A., Freund, K. F., Gaul, S. L., Saari, W. S., Wai, J. S., & Hoffman, J. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6863 · Cited by 279
Lin, T., Schinazi, R. F., & Prusoff, W. H. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90253-x · Cited by 261
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents
Pauwels, R., Balzarini, J., Schols, D., Baba, M., Desmyter, J., Rosenberg, I., Holy, A., & De Clercq, E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1025 · Cited by 256
Self-citationSoudeyns, H., Yao, X. I., Gao, Q., Belleau, B., Kraus, J. L., Nguyen-Ba, N., Spira, B., & Wainberg, M. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1386 · Cited by 237
Vince, R., Hua, M., Brownell, J., Daluge, S., Lee, F., Shannon, W. M., Lavelle, G. C., Qualls, J., Weislow, O. S., Kiser, R., et al. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80950-1 · Cited by 232
Hargrave, K. D., Proudfoot, J. R., Grozinger, K. G., Cullen, E., Kapadia, S. R., Patel, U. R., Fuchs, V. U., Mauldin, S. C., Vitous, J., Behnke, M. L., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00111a045 · Cited by 209
Ho, H. T., & Hitchcock, M. J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.6.844 · Cited by 195
Balzarini, J., Baba, M., Pauwels, R., Herdewijn, P., & De Clercq, E. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90049-4 · Cited by 191
Self-citationSensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus
Pauwels, R., De Clercq, E., Desmyter, J., Balzarini, J., Goubau, P., Herdewijn, P., Vanderhaeghe, H., & Vandeputte, M. (1987) · Journal of Virological Methods · doi:10.1016/0166-0934(87)90002-4 · Cited by 186
Self-citationBalzarini, J., Pauwels, R., Baba, M., Herdewijn, P., de Clercq, E., Broder, S., & Johns, D. G. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90178-5 · Cited by 185
Self-citationWu, J. C., Warren, T. C., Adams, J., Proudfoot, J., Skiles, J., Raghavan, P., Perry, C., Potocki, I., Farina, P. R., & Grob, P. M. (1991) · Biochemistry · doi:10.1021/bi00222a003 · Cited by 180
Boucher, C. A. B., Lange, J. M. A., Goudsmit, J., Mulder, J. W., Tersmette, M., de Goede, R. E. Y., Kellam, P., Darby, G., & Larder, B. A. (1990) · The Lancet · doi:10.1016/0140-6736(90)93391-2 · Cited by 179
Baba, M., De Clercq, E., Tanaka, H., Ubasawa, M., Takashima, H., Sekiya, K., Nitta, I., Umezu, K., Nakashima, H., & Mori, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2356 · Cited by 176
Self-citationRichman, D., Rosenthal, A. S., Skoog, M., Eckner, R. J., Chou, T. C., Sabo, J. P., & Merluzzi, V. J. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.2.305 · Cited by 158
Rich, D. H., Green, J., Toth, M. V., Marshall, G. R., & Kent, S. B. H. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00167a003 · Cited by 142
Nakashima, H., Matsui, T., Harada, S., Kobayashi, N., Matsuda, A., Ueda, T., & Yamamoto, N. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.6.933 · Cited by 127
Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogs
Kim, C. H., Márquez, V. E., Broder, S. E., Mitsuya, H., & Driscoll, J. S. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00388a020 · Cited by 113
Koup, R. A., Merluzzi, V. J., Hargrave, K. D., Adams, J., Grözinger, K. G., Eclmer, R. J., & Sullivan, J. L. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.5.966 · Cited by 110
Decreased In Vitro Susceptibility to Zidovudine of HIV Isolates Obtained from Patients with AIDS
Land, S., Treloar, G., McPhee, D. A., Birch, C. J., Doherty, R. R., Cooper, D. A., & Gust, I. D. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.2.326 · Cited by 102
Lin, T., Sohinazi, R. F., Chen, M. S., Kinney-Thomas, E., & Prusoff, W. H. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90287-5 · Cited by 101
(±)-Dioxolane-T ((±)-1-[(2β,4β)-2-(hydroxymethyl)-4-dioxolanyl]thymine)
Norbeck, D. W., Spanton, S. G., Broder, S. E., & Mitsuya, H. (1989) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)93868-7 · Cited by 96
New acquisitions in the development of anti-HIV agents
Clercq, E. D. (1989) · Antiviral Research · doi:10.1016/0166-3542(89)90064-8 · Cited by 93
Chu, C. K., Schinazi, R. F., Arnold, B. H., Cannon, D. L., Doboszewski, B., Bhadti, V. B., & Gu, Z. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90383-8 · Cited by 78
Hayashi, S., Norbeck, D. W., ROSENBROOK, W. J., Fine, R. L., Matsukura, M., PLATTNER, J. J., Broder, S., & Mitsuya, H. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.287 · Cited by 78
Webb, T. R., Mitsuya, H., & Broder, S. E. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00402a038 · Cited by 72
An analysis of the inhibition of replication of HOV and MULV by some 3′-blocked pyrimidine analogs
Bazin, H., CHATTOPADHYAYA, J. B., DATEMA, R., Ericson, A.-C., Gilljam, G., Johansson, N. G., Hansen, J., Koshida, R., Moelling, K., Öberg, B. F., et al. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90157-3 · Cited by 70
Hartmann, H., Vogt, M. W., Durno, A. G., Hirsch, M., Hunsmann, G., & Eckstein, F. (1988) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1988.4.457 · Cited by 60
Shirasaka, T., Murakami, K., Ford, H., Kelley, J. A., YOSHIOKA, H., Kojima, E., Aoki, S., Broder, S., & Mitsuya, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9426 · Cited by 57
Seki, J., Shimada, N., Takahashi, K., TAKITA, T., Takeuchi, T., & Hoshino, H. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.5.773 · Cited by 51
Eriksson, B., CHU, C. K., & Schinazi, R. F. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1729 · Cited by 50
Schinazi, R. F., Eriksson, B., & Hughes, S. H. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.1.115 · Cited by 33
Inhibition of human immunodeficiency virus 1 reverse transcriptase by 3′‐azidothymidine triphosphate
Heidenreich, O. T., Kruhøffer, M., Große, F., & Eckstein, F. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19268.x · Cited by 29
Effect of 3'-deoxythymidin-2'-ene (d4T) on nucleoside metabolism in H9 cells
Marongiu, M. E., Auoust, E. M., & Prusoff, W. H. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90516-n · Cited by 15
Synthesis of 3′-O-Propargylthymidine as a Candidate Antiretroviral Agent
Rosowsky, A., Ruprecht, R. M., & Solan, V. C. (1989) · Nucleosides and Nucleotides · doi:10.1080/07328318908054191 · Cited by 6
Cited by
Havlir, D., Cheeseman, S. H., Mclaughlin, M., Murphy, R., Erice, A., Spector, S. A., Greenough, T. C., Sullivan, J. L., Hall, D., Myers, M., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.3.537 · Cited by 298
Arnold, J. J., & Cameron, C. E. (2004) · Biochemistry · doi:10.1021/bi035212y · Cited by 178
Metadata
- Authors
- DE CLERCQ, E.
- Venue
- AIDS Research and Human Retroviruses
- Publisher
- SAGE Publications
- Published
- 1992-02
- Volume
- 8
- Issue
- 2
- Pages
- 119-134
- ISSN
- 0889-2229 (ISSN-L)
- 1931-8405
- OpenAlex
- W1976580962
- Cited by
- 262
- References
- 45
- FWCI
- 26.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.